Related references
Note: Only part of the references are listed.Angiogenin and Hemoxygenase in Pregnancy: Influence of Hypertension
Velore J. Karthikeyan et al.
ANGIOLOGY (2012)
Matrix metalloproteinases and soluble Fas/FasL system as novel regulators of apoptosis in children and young adults on chronic dialysis
Kinga Musial et al.
APOPTOSIS (2011)
Tissue inhibitor of matrix metalloproteinase 1 (TIMP1) controls adipogenesis in obesity in mice and in humans
B. Meissburger et al.
DIABETOLOGIA (2011)
Exercise training reduces serum capacity to induce endothelial cell death in patients with chronic heart failure
Caterina Mammi et al.
EUROPEAN JOURNAL OF HEART FAILURE (2011)
Clinical significance of serum levels of matrix metalloproteinase 2 (MMP-2) and its tissue inhibitor (TIMP-2) in gastric cancer
Barbara Mroczko et al.
FOLIA HISTOCHEMICA ET CYTOBIOLOGICA (2011)
Matrix metalloproteinases and their inhibitors and inducer in gestational trophoblastic diseases and normal placenta
Margit Singh et al.
GYNECOLOGIC ONCOLOGY (2011)
Dynamic Interdomain Interactions Contribute to the Inhibition of Matrix Metalloproteinases by Tissue Inhibitors of Metalloproteinases
Albert G. Remacle et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Plasma TIMP-4 Predicts Left Ventricular Remodeling After Acute Myocardial Infarction
Robin A. P. Weir et al.
JOURNAL OF CARDIAC FAILURE (2011)
Impact of Biomarkers of Inflammation and Extracellular Matrix Turnover on the Outcome of Atrial Fibrillation Ablation: Importance of Matrix Metalloproteinase-2 as a Predictor of Atrial Fibrillation Recurrence
Yasuo Okumura et al.
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY (2011)
Human decidua and invasive trophoblasts are rich sources of nearly all human matrix metalloproteinases
Jelena Anacker et al.
MOLECULAR HUMAN REPRODUCTION (2011)
Biomarkers of Extracellular Matrix Metabolism (MMP-9 and TIMP-1) and Risk of Stroke, Myocardial Infarction, and Cause-Specific Mortality: Cohort Study
Jonas Hansson et al.
PLOS ONE (2011)
Levels of matrix metalloproteinase-1 and tissue inhibitors of metalloproteinase-1 in gastric cancer
Ozgur Kemik et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
Enhancement of in vitro human tubulogenesis by endothelial cell-derived factors: implications for in vivo tubular regeneration after injury
Masaaki Miya et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2011)
Relation of Matrix Metalloproteinase-9/Tissue Inhibitor of Metalloproteinase-1 Ratio in Peripheral Circulating CD14+Monocytes to Progression of Coronary Artery Disease
Stefan Brunner et al.
AMERICAN JOURNAL OF CARDIOLOGY (2010)
Usefulness of Plasma Tissue Inhibitors of Metalloproteinases as Markers of Prognosis After Acute Myocardial Infarction
Dominic Kelly et al.
AMERICAN JOURNAL OF CARDIOLOGY (2010)
Relations of Biomarkers of Extracellular Matrix Remodeling to Incident Cardiovascular Events and Mortality
Raghava S. Velagaleti et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
Imbalance of Matrix Metalloproteinases/Tissue Inhibitor of Metalloproteinase-1 and Loss of Fibronectin Expression in Patients with Congestive Heart Failure
Da-chun Yang et al.
CARDIOLOGY (2010)
Hypertension in Pregnancy A Comprehensive Update
Belinda Jim et al.
CARDIOLOGY IN REVIEW (2010)
TIMP2 Deficiency Accelerates Adverse Post-Myocardial Infarction Remodeling Because of Enhanced MT1-MMP Activity Despite Lack of MMP2 Activation
Vijay Kandalam et al.
CIRCULATION RESEARCH (2010)
Endothelial cell activation by tumour necrosis factor-alpha (TNF-α and the development of pre-eclampsia
J. W. MEEKINS et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Matrix metalloproteinases, MMP-7 and MMP-26, in plasma and serum of control and preeclamptic umbilical cord blood
Zofia Galewska et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2010)
Imbalance between matrix metalloproteinases and tissue inhibitor of metalloproteinases in hypertensive vascular remodeling
Michele M. Castro et al.
MATRIX BIOLOGY (2010)
Trophoblast-Vascular Cell Interactions in Early Pregnancy: How to Remodel a Vessel
L. K. Harris
PLACENTA (2010)
Remodelling at the maternal-fetal interface: relevance to human pregnancy disorders
Judith E. Cartwright et al.
REPRODUCTION (2010)
Plasma haemoxygenase-1 in coronary artery disease A comparison with angiogenin, matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1 and vascular endothelial growth factor
Naglaa K. Idriss et al.
THROMBOSIS AND HAEMOSTASIS (2010)
Characterisation and validity of inflammatory biomarkers in the prediction of post-operative atrial fibrillation in coronary artery disease patients
Diana Kaireviciute et al.
THROMBOSIS AND HAEMOSTASIS (2010)
MMP-2/TIMP-2/TIMP-4 versus MMP-9/TIMP-3 in transition from compensatory hypertrophy and angiogenesis to decompensatory heart failure*
Srikanth Givvimani et al.
ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY (2010)
Genetic polymorphisms of matrix metalloproteinases and their inhibitors in potentially malignant and malignant lesions of the head and neck
Ajay Kumar Chaudhary et al.
JOURNAL OF BIOMEDICAL SCIENCE (2010)
Serum levels of large tenascin-C variants, matrix metalloproteinase-9, and tissue inhibitors of matrix metalloproteinases in concentric versus eccentric left ventricular hypertrophy
Marcus Franz et al.
EUROPEAN JOURNAL OF HEART FAILURE (2009)
Evaluation of Metalloproteinases 2 and 9 and Their Inhibitors in Physiologic and Pre-eclamptic Pregnancy
Martina Montagnana et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2009)
Preeclampsia: The Role of Angiogenic Factors in Its Pathogenesis
Alice Wang et al.
PHYSIOLOGY (2009)
Matrix metalloproteinase-2 is elevated in midtrimester amniotic fluid prior to the development of preeclampsia
Michal Lavee et al.
REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY (2009)
Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease
Joseph D. Raffetto et al.
BIOCHEMICAL PHARMACOLOGY (2008)
Comparative assessment of matrix metalloproteinase (MMP)-2 and MMP-9, and their inhibitors, tissue inhibitors of metalloproteinase (TIMP)-1 and TIMP-2 in preeclampsia and gestational hypertension
Ana C. T. Palei et al.
CLINICAL BIOCHEMISTRY (2008)
Gelatinase matrix metalloproteinase (MMP)-2 and MMP-9 of the umbilical cord blood in preeclampsia
Zofia Galewska et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2008)
Novel Biomarkers for Predicting Preeclampsia
David M. Carty et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2008)
Chemokine and cytokine processing by matrix metalloproteinases and its effect on leukocyte migration and inflammation
Philippe Van Lint et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
Impact of the metalloproteinase-9/tissue inhibitor of metalloproteinase-1 system on large arterial stiffness in patients with essential hypertension
Jing Tan et al.
HYPERTENSION RESEARCH (2007)
Myocardial matrix remodeling and the matrix metalloproteinases: Influence on cardiac form and function
Francis G. Spinale
PHYSIOLOGICAL REVIEWS (2007)
Matrix metalloproteinases: control of vascular function and their potential role in preeclampsia
Manoj Mathew Lalu et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2007)
High plasma levels of tissue inhibitor of metalloproteinase-1 (TIMP-1) and interleukin-8 (IL-8) characterize patients prone to ventricular fibrillation complicating myocardial infarction
Elif Elmas et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2007)
Collagen type-I degradation is related to arterial stiffness in hypertensive and normotensive subjects
M. McNulty et al.
JOURNAL OF HUMAN HYPERTENSION (2006)
Matrix metalloproteinases/tissue inhibitors of metalloproteinases - Relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease
SH Ahmed et al.
CIRCULATION (2006)
Matrix metalloproteinase-2,-9, and tissue inhibitor of metalloproteinase-1 in patients with hypertension
Giuseppe Derosa et al.
ENDOTHELIUM-JOURNAL OF ENDOTHELIAL CELL RESEARCH (2006)
Pericellular proteases in angiogenesis and vasculogenesis
VWM van Hinsbergh et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Contribution of plasma matrix metalloproteinases to development of left ventricular hypertrophy and diastolic dysfunction in hypertensive subjects
M Saglam et al.
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Activin A and inhibin A differentially regulate human uterine matrix metalloproteinases: Potential interactions during decidualization and trophoblast invasion
RL Jones et al.
ENDOCRINOLOGY (2006)
TNF-receptor levels in preeclampsia - results of a longitudinal study in high-risk women
EJI Schipper et al.
JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE (2005)
Increased cardiac expression of tissue inhibitor of metalloproteinase-1 and tissue inhibitor of metalloproteinase-2 is related to cardiac fibrosis and dysfunction in the chronic pressure-overloaded human heart
S Heymans et al.
CIRCULATION (2005)
Circulating matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases-1 and-2 levels in gestational hypertension
MH Tayebjee et al.
AMERICAN JOURNAL OF HYPERTENSION (2005)
Matrix metalloproteinases and diabetic vascular complications
NP Kadoglou et al.
ANGIOLOGY (2005)
Matrix metalloproteinase-9 (MMP-9), MMP-2, and serum elastase activity are associated with systolic hypertension and arterial stiffness
Yasmin et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
MMP-2 levels are elevated in the plasma of women who subsequently develop preeclampsia
JE Myers et al.
HYPERTENSION IN PREGNANCY (2005)
The role of matrix metalloproteinases in vascular function: implications for normal pregnancy and pre-eclampsia
SJ Merchant et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2004)
Downregulation of vascular matrix metalloproteinase inducer and activator proteins in hypertensive patients
A Ergul et al.
AMERICAN JOURNAL OF HYPERTENSION (2004)
MT1-MMP and MMP-7 in invasion and metastasis of human cancers
T Shiomi et al.
CANCER AND METASTASIS REVIEWS (2003)
Gestational profile of matrix metalloproteinases in rat uterine artery
BA Kelly et al.
MOLECULAR HUMAN REPRODUCTION (2003)
Cell surface association of matrix metalloproteinase-9 (gelatinase B)
R Fridman et al.
CANCER AND METASTASIS REVIEWS (2003)
Matrix metalloproteinases and tissue inhibitors of metalloproteinases - Structure, function, and biochemistry
R Visse et al.
CIRCULATION RESEARCH (2003)
Is thrombogenesis in atrial fibrillation related to matrix metalloproteinase-1 and its inhibitor, TIMP-1?
F Marín et al.
STROKE (2003)
Plasma levels of active extracellular matrix metalloproteinases 2 and 9 in patients with essential hypertension before and after anti hypertensive treatment
A Zervoudaki et al.
JOURNAL OF HUMAN HYPERTENSION (2003)
Angiogenesis during primate placentation in health and disease
C Wulff et al.
REPRODUCTION (2003)
Expression and activity of matrix metalloproteinase 2 and 9 in human trophoblasts
K Isaka et al.
PLACENTA (2003)
Matrix metalloprotease-9, placental syncytiotrophoblast and the endothelial dysfunction of pre-eclampsia
CA de Jager et al.
PLACENTA (2003)
Plasma matrix metalloproteinase and inhibitor profiles in patients with heart failure
EM Wilson et al.
JOURNAL OF CARDIAC FAILURE (2002)
Matrix metalloproteinase-2 is elevated in the plasma of women with preeclampsia
H Narumiya et al.
HYPERTENSION IN PREGNANCY (2001)
Polarized release of matrix metalloproteinase-2 and-9 from cultured human placental syncytiotrophoblasts
G Sawicki et al.
BIOLOGY OF REPRODUCTION (2000)
Atrial flutter in grown-up congenital heart (GUCH) patients - Clinical characteristics of affected population
W Li et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2000)
Gelatinase B deficiency impairs reproduction
B Dubois et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Share Paper
